BACKGROUND
The goal of protecting hospitalized patients from the development of nosocomial infection is one which impacts both the safety and well-being of our patients and the economic health of our institutions. [1] [2] [3] [4] [5] [6] [7] Newly released guidelines from the Joint Commission have mandated that intravenous (IV) solution bags be spiked no sooner than 1 hour prior to use, and discarded after that 1-hour period. 1, 3, 8 This major change in practice could create an unintended problem by decreasing the ability of clinicians in acute care environments to have IV fluids spiked and ready for critical timesensitive emergencies. Those advocating for this change in the use of spiked IV bags stated the following: "This recommendation for immediate-use CSPs [compounded sterile preparations] is a controversial unresolved issue and in actual practice difficult to comply with in certain settings." (underscore inserted by authors of study). 3 A review of the literature reveals no prospective studies of the degree to which IV fluids become contaminated over time. 9 Our current study seeks to determine if spiking an IV bag of Lactated Ringers (LR) produces bacterial growth in the IV fluid over time.
MATERIALS AND METHODS
This study was reviewed by the facility's institutional review board, who determined this project was not under the purview of the institutional review board per federal regulations. This experimental study was designed to determine differences in bacterial growth after spiking of the IV bags containing LR solution using a univariate Kruskal-Wallis test. 10 The choice of LR was made to most closely approximate a normal daily anesthesia department routine, in which nearly all patients receive this solution. Samples would be grouped by the time the specimen was obtained. These 5 groups were at the time of spiking and 1, 2, 4, and 8 hours after spiking. The laboratory director would then rate the growth as a univariate ordinal measure of bacterial growth (0 [none] to 4 [heavy]). The specimen containers would be identified by a randomly assigned number.
After initially proposing an α of 0.05 and a power of 0.8, the research team was faced with addressing what would be an appropriate effect size, made more difficult by the lack of previous experimental studies. One cannot directly provide power analysis for nonparametric tests; therefore, the analogous parametric test, a univariate analysis of variance, was used to determine the initial calculations. Cohen's seminal text on power states that a large effect size correlated with greater test power, assuming adequate significance criteria and sample size. 11 Using the G*Power3 software program (University of Kiel, Kiel, Germany), we inserted an effect size (f index) of 0.4 (described as large). The f index is described as a unitless number referring to the SD of the standardized means of the variable groups (in this case the mean growth in each of the sampling groups). 11 The formula for the f index is as follows:
where σm 2 is the variance of all means and σ 2 is the variance within the samples. 11 The entry of these data points resulted in a total sample size of 80 specimens to meet the power standard. 12 Values >0.4 of the SD of the standardized means of bacterial growth in any group would therefore be significant. Creating a faux spreadsheet, we set up conditions in which 3 of 80 spurious samples had reported light growth, resulting in an f index of 0.43; therefore, our study would have been sensitive to as few as 3 of 80 samples being contaminated with the lightest possible bacterial growth. Because we also intended to report descriptive statistics, any bacterial growth at any time would also have been noted.
The sample size results needed for the nonparametric Kruskal-Wallis test were then determined using the reported asymptotic relative efficiency of the nonparametric test. The result was an efficiency ratio of 1.0-1.047, in essence, no difference from the sample size needed for the analysis of variance. 10 A primary goal was to obtain the samples in a fashion which paralleled normal clinical practice, that is one IV bag and administration set for each sample were used, just as the clinician would use one set for one patient one time. 4 The LR bags were spiked with a standard IV administration set, and the lines were purged in a fashion to prevent an air-water interface at the end of the tubing (ie, allowing a small air space 1-2 cm from the end of the administration set; the fluids were not allowed to drip out of the end of the set). A certified registered nurse anesthetist on the research team performed standard hand hygiene and then spiked the IV bags. At the specified times, a certified registered nurse anesthetist from the team placed samples of the IV fluid in sterile specimen containers after standard hand hygiene was performed and nonsterile procedure gloves were donned. Then 50-60 mL of IV fluids were drained into the container: because the administration set contained 27 mL of fluid, using 50-60 mL of fluid assured that the sample came from the IV bag and the administration tubing.
Eight sham samples were also obtained. Four of these sham samples were intentionally contaminated with Escherichia coli bacteria provided from the laboratory (identified as sham positive), whereas the other 4 were simply sterile irrigant saline (labeled as sham negative) poured into the specimen containers. The sham samples confirmed the integrity of the blood agar plates (BAPs) and ensured that the specimens were being properly plated because continued measures of no growth could have been indicative of improper plating by laboratory personnel.
Each sample came to the microbiology laboratory in a sterile specimen container labeled with a number and was placed under a ductless filtering fume hood for processing. Medical laboratory science (MLS) interns were responsible for proper plating of the samples. The interns had all completed training in this area of microbiology and were deemed competent and were supervised by either the director of the MLS program or the microbiology clinical instructor. Samples were processed within 1-2 hours of arriving in the laboratory. Donning a new pair of powder-free examination gloves, the intern selected a sterile BAP and labeled the plate with the corresponding sample number and date. The sample contain-er was then inverted 4-5 times to ensure the sample was mixed. After being placed under the hood, the lid was removed from the specimen bottle containing the sample. A sterile 100-μL loop was dipped into the liquid, removing a loop-size sample for streaking and quantitative purposes. The sample in the loop was then transferred onto the BAP using the standard isolation streaking method. 13 A single vertical streak line was drawn down the center of the BAP. The loop was then streaked back and forth across the inoculum line beginning at one end of the line with a tight pattern and then increasing the gap of the streaks as the loop was moved back and forth down the plate in the usual fashion. 13 The now inoculated BAP was placed into a 35°C-37°C incubator. Daily quality control confirmed that the incubator maintained its proper temperature each day. The sample BAPs were observed by both the interns and the MLS director for any kind of growth at both 24 and 48 hours after plating. None of the individuals reading the plates knew the times at which the specimens were obtained.
RESULTS
There was no growth in any of the IV samples at any of the times tested at either 24 or 48 hours after plating (Table 1) . These results precluded the use of a Kruskal-Wallis test. To calculate the likelihood of 80 samples showing no growth simply because of random chance, the calculation for binomial probability 14 (for the results growth or no growth) was performed, with a P < .00001. Our sham specimens were also plated: 100% of the BAPs showed heavy growth of E coli in the sham-positive plates, whereas 0% of the BAPs showed growth in the sham-negative plates. The probability of the correct results in 8 of 8 sham-positive samples solely because of random effects is P = .0039.
DISCUSSION
This study was designed to determine the likelihood of bacterial growth occurring in LR IV fluids hung in an environment where they could be easily accessed by staff. We took no special steps in spiking the bags and drawing the samples other than those used in the normal course of patient care. We took quality control steps for laboratory plating and evaluation of bacterial growth and limited our samples to those containing LR solution. There may be different results in IVs containing glucose, or in solutions of normal saline. We believe that investigating across solution types merits further research.
CONCLUSIONS
We believe that policies restricting spiking of LR IV bags 1 hour prior to use, although well-intentioned, are not supported by the evidence presented in this blinded study. We urge policymakers to reconsider their stance in this regard. We also encourage further research with other fluids, especially those containing glucose, which are conceivably more conducive to bacterial growth. 
